Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

15.63
Delayed Data
As of May 25
 +0.35 / +2.29%
Today’s Change
12.61
Today|||52-Week Range
109.24
-29.78%
Year-to-Date
No recent news for Esperion Therapeutics Inc.

Today’s Trading

Previous close15.28
Today’s open15.35
Day’s range15.05 - 15.75
Volume243,829
Average volume (3 months)456,890
Market cap$344.4M
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)-1.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+22.06%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
CGENCompugen Ltd+0.03+0.43%
VYGRVoyager Therapeutics...+0.26+2.08%
AGENAgenus Inc0.000.00%
NDRMNeuroderm Ltd+0.32+1.82%
Data as of 05/25/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$0.00
Annual profit (last year)-$49.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

Partner Offers

Search for Jobs